Masayuki Fukuzawa

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Oral Anticoagulants

Placebo Controlled

Top Venues

Journal of the American Heart Association

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Masaharu Akao, Takeshi Yamashita, Masayuki Fukuzawa, Takuya Hayashi, Ken Okumura
Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial. Journal of the American Heart Association 13 (3) (2024)
Masaharu Akao, Takeshi Yamashita, Masayuki Fukuzawa, Takuya Hayashi, Ken Okumura
Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial. Journal of the American Heart Association (2024)
Masaharu Akao, Takeshi Yamashita, Masayuki Fukuzawa, Takuya Hayashi, Ken Okumura
Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial. Journal of the American Heart Association 13 (3) (2024)
Masaharu Akao, Takeshi Yamashita, Masayuki Fukuzawa, Takuya Hayashi, Ken Okumura
Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial. Journal of the American Heart Association 13 (3) (2024)
Masaharu Akao, Takeshi Yamashita, Masayuki Fukuzawa, Takuya Hayashi, Ken Okumura
Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial. Journal of the American Heart Association 13 (3) (2024)
Ken Okumura, Masaharu Akao, Tetsuro Yoshida, Masahito Kawata, Osamu Okazaki, Shintaro Akashi, Kenichi Eshima, Kimihiko Tanizawa, Masayuki Fukuzawa, Takuya Hayashi, Masahiro Akishita, Gregory Y H Lip, Takeshi Yamashita, null null
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. The New England journal of medicine 383 (18) (2020)